ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselAnaveon AG
Anaveon AG Logo
Verified· 3 sources

Anaveon AG

Summary

About the company

Anaveon is a biotechnology company specializing in the development of pharmaceutical products, particularly immunotherapies. The company's core activity encompasses the research and development of therapeutic candidates, ranging from discovery to clinical testing. Anaveon focuses on treating immune-mediated diseases and has expertise in the areas of autoimmunity, transplantation, and inflammation.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered5
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Development of precision biologics
Development of precision biologics, engineered antibodies and cytokine-based therapies to selectively modulate the immune system in autoimmune and inflammatory diseases.
Immunology pipeline
Development of immunology programs focused on ANV200 and additional pipeline candidates to eliminate or reprogram pathogenic immune cells.
ANV200
PD-1-depleting antibody in preclinical development for autoimmune diseases; intended to deeply deplete pathogenic T cells and reset inflammatory immune responses.
Collaboration and partnerships
Licensing, co-development or acquisition for the oncology portfolio, as well as partnering inquiries for the further development of selected programs.
Oncology portfolio
Legacy oncology assets with ANV600, ANV700 and other preclinical or clinical programs; focus on development and potential partnerships.
Press

Media

April 8, 2026Media
Swiss startups appoint new CEOs and senior hires across biotech, AI and proptech
startupticker.ch
January 6, 2025Media
Executive reshuffle in four startups
startupticker.ch
June 11, 2024Media
Biotech startups make clinical progress
startupticker.ch

Knowledge

No knowledge articles yet

Once Anaveon AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Anaveon AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Anaveon AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Anaveon AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60C
4057 Basel
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-232.476.299
Founded
2017 · 9 years
Last commercial register change
April 20, 2026
Employees
21 to 50

Similar companies

TT
TOLREMO therapeutics AG
Basel
MP
Mepha Pharma AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel